Authors:
LANYI A
DEB D
SEYMOUR RC
LUDESMEYERS JH
SUBLER MA
DEB S
Citation: A. Lanyi et al., GAIN OF FUNCTION PHENOTYPE OF TUMOR-DERIVED MUTANT P53 REQUIRES THE OLIGOMERIZATION NONSEQUENCE-SPECIFIC NUCLEIC ACID-BINDING DOMAIN/, Oncogene, 16(24), 1998, pp. 3169-3176
Authors:
KOESTER SK
MAENPAA JU
WIEBE VJ
BAKER WJ
WURZ GT
SEYMOUR RC
KOEHLER RE
DEGREGORIO MW
Citation: Sk. Koester et al., FLOW-CYTOMETRY - POTENTIAL UTILITY IN MONITORING DRUG EFFECTS IN BREAST-CANCER, Breast cancer research and treatment, 32(1), 1994, pp. 57-65
Authors:
BAKER WJ
MAENPAA JU
WURZ GT
KOESTER SK
SEYMOUR RC
EMSHOFF VD
WIEBE VJ
DEGREGORIO MW
Citation: Wj. Baker et al., TOREMIFENE ENHANCES CELL-CYCLE BLOCK AND GROWTH-INHIBITION BY VINBLASTINE IN MULTIDRUG-RESISTANT HUMAN BREAST-CANCER CELLS, Oncology research, 5(6-7), 1993, pp. 207-212
Authors:
MAENPAA JU
WURZ GT
BAKER WJ
WIEBE VJ
EMSHOFF VD
KOESTER SK
SEYMOUR RC
KOEHLER RE
DEGREGORIO MW
Citation: Ju. Maenpaa et al., A BREAST-CANCER CLONE SELECTED BY TAMOXIFEN HAS INCREASED GROWTH-RATEAND REDUCED SENSITIVITY TO DOXORUBICIN, Oncology research, 5(12), 1993, pp. 461-466
Authors:
SIPILA PEH
WIEBE VJ
HUBBARD GB
KOESTER SK
EMSHOFF VD
MAENPAA JU
WURZ GT
SEYMOUR RC
DEGREGORIO MW
Citation: Peh. Sipila et al., PROLONGED TAMOXIFEN EXPOSURE SELECTS A BREAST-CANCER CELL CLONE THAT IS STABLE IN-VITRO AND IN-VIVO, European journal of cancer, 29A(15), 1993, pp. 2138-2144